Medical/Pharmaceuticals
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
* Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. * The new brand structure reflects the scientific journey, connecting early discoveries to translational...
2026-04-16 20:49
3839
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
SAN DIEGO and NEW YORK, April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the leading academic health systems in the United States, will adopt the AI-powered SOPHiA DDM™ Platfo...
2026-04-16 20:00
3738
After 35 Years with Parkinson's Disease and a Life-Threatening Infection, One Patient Reclaimed Independent Living
SHANGHAI, April 16, 2026 /PRNewswire/ -- On World Parkinson's Day, Jiahui International Hospital shares an extraordinary case highlighting advanced Parkinson's disease care complexity, multidisciplinary collaboration, and functional recovery despite life‑threatening complications. A 75‑year‑old ...
2026-04-16 18:59
2710
Mabwell Establishes a Licensing and Commercialization Agreement for Denosumab Biosimilars in Malaysian Market
SHANGHAI, April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has established a licensing and commercialization agreement with a strategic business partner ("the partner") in Malaysia for its...
2026-04-16 17:00
5359
First Ever APAC Pharmacists' Guideline to Tackle Peripheral Neuropathy
Developed By APAC Pharmacist Experts - 1 in 2 diabetics, and 1 in 10 adults suffer from Peripheral Neuropathy [1],[2] - Community pharmacists first and most accessible point of healthcare contact - New guidelines highlight emerging role of pharmacists in elevating the standard of care SIN...
2026-04-16 12:00
3565
Global First | NMPA Accepts IND Application for Mabwell's Innovative LILRB4/CD3 TCE Bispecific Antibody 6MW5311
SHANGHAI, April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the National Medical Products Administration (NMPA) has accepted the Investigational New Drug (IND) application for its innovative L...
2026-04-16 11:36
5677
Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)
SHANGHAI, April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with a full industry chain, announced that the National Medical Products Administration (NMPA) has accepted supplemental Biologics License Application for MAIWEIJIAN (denosumab injection, R&D cod...
2026-04-16 08:00
4352
Osara Health Publishes New Peer-Reviewed Study Demonstrating Clinically Meaningful Improvements in Physical and Mental Health for People With Cancer
Findings published in JMIR Cancer show measurable health gains for Osara Health
participants, adding to a growing evidence base including a 25:1 independently
validated return on investment.
NEW YORK, April 15, 2026 /PRNewswire/ -- Osara Health
2026-04-15 20:00
3156
Reach Surgical Receives CE Mark Approval for iREACH IRIS, First Powered Reusable Stapler with Real-Time Firing Curve™ and 90° Articulation
-iREACH IRIS provides real-time, location-specific insight into tissue behaviour along the staple line SINGAPORE, April 15, 2026 /PRNewswire/ -- Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for iREACH IRIS, a next-generation powered stapling p...
2026-04-15 11:30
2238
SinoUnited Health Attracts International Patients as China Emerges as Global Medical Tourism Destination
SHANGHAI, April 14, 2026 /PRNewswire/ -- From CAR-T Cell Therapy and cardiac interventions to health checkups and dental care, China's medical capabilities have increasingly drawn international patients in recent years—underscoring the country's rising influence in the global healthcare landscape...
2026-04-15 09:17
3384
SST001, an α-syn PET tracer from Mabwell's incubated company SynuSight Biotech, received NMPA approval to initiate a clinical trial
SHANGHAI, April 15, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that18F-FD4 (R&D code: SST001), an α-synuclein (α-syn) targeted PET tracer independently developed by its incubated company SynuSight Bio...
2026-04-15 08:00
4651
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed with TLX101-Tx (¹³¹I-iodofalan) in Telix's pivotal IPAX BrIGHT trial[1], marking the first radiopharmaceutical...
2026-04-15 06:50
4403
Telix Successfully Prices and Upsizes US$600 Million Convertible Bonds
MELBOURNE, Australia and Indianapolis, April 15, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) ("Telix") is pleased to announce that it has successfully priced and upsized its 1.50 per cent convertible notes due 2031 to be issued by its wholly-owned subsidiary, Telix ...
2026-04-15 06:35
5785
NYSE Content Update: OpenLoop Health Debuts At-Home Sleep Apnea Test with 98% Accuracy
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 14, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begi...
2026-04-14 21:03
6626
Telix Refinances Convertible Bonds
MELBOURNE, Australia and INDIANAPOLIS, Ind., April 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) ("Telix") today launches an offering of US$550 million convertible notes due 2031 to be issued by its wholly-owned subsidiary, Telix Pharmaceuticals (Investments) Inc....
2026-04-14 16:32
6170
triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy
All-in-one approach integrates chromosomal analysis, single-gene disorder
screening, and maternal carrier screening from a single blood draw.
TAIPEI, April 14, 2026 /PRNewswire/ -- At the prestigious Taiwan Association
of Obstetrics and Gynecology
2026-04-14 11:30
4291
Kelun-Biotech Announces Results from the SKB264-II-06/MK-2870-002 Study of Sacituzumab Tirumotecan (Sac-TMT) in Gynecologic Oncology Presented at 2026 SGO
CHENGDU, China, April 14, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that results from both the ovarian cancer cohort and the cervical cancer cohort of Phase II study SKB264-II-06/MK-2870-002 of the TROP2 ADC sacit...
2026-04-14 08:00
6478
Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC
The DOORwaY90 study met its prespecified co-primary endpoints, achieving a best
overall response rate (ORR) of 99%
WOBURN, Mass., April 13, 2026 /PRNewswire/ -- Sirtex Medical ("Sirtex")
2026-04-13 21:00
4654
PANVIS STAR Vascular Interventional Robotic System Redefines Mechanical Thrombectomy
BEIJING, April 13, 2026 /PRNewswire/ -- In 2021, there were 11.96 million new stroke cases worldwide, with ischemic stroke (IS) accounting for 65.3%. China has an estimated 17.8 million stroke survivors, 86.8% of which are ischemic. For large vessel occlusion (LVO), mechanical thrombectomy (MT) i...
2026-04-13 20:41
3910
Noah Medical Launches Deep-Dive Research Series on Medical Robotics Value
Why the World's Leading Medical Robotics Companies Put Clinical Value First This article serves as a foundational study for the Noah Medical deep-dive series, aiming to help investors establish a core framework for assessing value in the medical robotics industry. HONG KONG, April 13, 2026 /PRNe...
2026-04-13 17:40
3307
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 305 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 302 media titles]
2026-05-19 23:59
Hong Leong Bank Awarded Best Managed Bank in Malaysia by The Asian Banker, Group MD/CEO Kevin Lam Named Best Bank CEO in Malaysia
[Picked up by 293 media titles]
2026-05-15 17:00
Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 289 media titles]
2026-05-18 15:30
AIMX Singapore 2026 Anchors Strategic Relationship with TechInnovation and AI Gravity
[Picked up by 279 media titles]
2026-05-19 14:00
Most Read
H World Group Reports Q1 Results, Highlighting Asset-light Growth and Expanding APAC Footprint
2026-05-15 20:11
7576
